Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORVEL CORP Director's Dealing 2014

Feb 12, 2014

31179_dirs_2014-02-12_2a7fe2cb-8cf9-4274-b8c6-5748f660ccd1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORVEL CORP (CRVL)
CIK: 0000874866
Period of Report: 2014-02-10

Reporting Person: McFarlane Donald C (Chief Information Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-10 Common Stock M 400 $12.71 Acquired 2140 Direct
2014-02-10 Common Stock S 400 $44.65 Disposed 1740 Direct
2014-02-10 Common Stock M 137 $12.71 Acquired 1877 Direct
2014-02-10 Common Stock S 137 $44.66 Disposed 1740 Direct
2014-02-10 Common Stock M 28 $12.71 Acquired 1768 Direct
2014-02-10 Common Stock S 28 $44.68 Disposed 1740 Direct
2014-02-10 Common Stock M 312 $12.71 Acquired 2052 Direct
2014-02-10 Common Stock S 312 $44.7 Disposed 1740 Direct
2014-02-10 Common Stock M 3 $12.71 Acquired 1743 Direct
2014-02-10 Common Stock S 3 $44.76 Disposed 1740 Direct
2014-02-10 Common Stock M 620 $12.71 Acquired 2360 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-10 Non-Qualified Stock Option (right to buy) $12.71 M 400 Disposed 2014-08-06 Common Stock (400) Direct
2014-02-10 Non-Qualified Stock Option (right to buy) $12.71 M 137 Disposed 2014-08-06 Common Stock (137) Direct
2014-02-10 Non-Qualified Stock Option (right to buy) $12.71 M 28 Disposed 2014-08-06 Common Stock (28) Direct
2014-02-10 Non-Qualified Stock Option (right to buy) $12.71 M 312 Disposed 2014-08-06 Common Stock (312) Direct
2014-02-10 Non-Qualified Stock Option (right to buy) $12.71 M 3 Disposed 2014-08-06 Common Stock (3) Direct
2014-02-10 Non-Qualified Stock Option (right to buy) $12.71 M 620 Disposed 2014-08-06 Common Stock (620) Direct

Footnotes

F1: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.